Clinical trials on the efficacy of a novel COVID-19 drug Paxlovid will enlist 90 participants. Pfizer, a pharmaceutical corporation based in the United States, has been granted permission by Russian authorities to test Paxlovid. The medicine will be studied in Russia until March 2023, although it is known that roughly 7,000 people in other countries have already begun…
On November 2, registration for the COVID-19 booster vaccination for adults began, provided it has been at least six months since receiving the full vaccination. As of mid-September, only people over the age of 50, medical personnel in contact with patients, and people who are immunocompromised could make appointments for the booster vaccination. The booster shot…
New variants of Covid-19 mean that scientists are constantly looking for solutions to effectively protect as many people as possible from serious complications when infected with the virus. BioNTech’s CEO has announced that a new vaccine formulation needs to be developed to protect more effectively against new mutations of the disease, which are likely to…
Merck (MSD) has agreed to buy Acceleron Pharma’s outstanding shares for $180 in cash per share and a total equity value of $11.5bn. The transaction includes the transfer of rights to Acceleron’s lead therapy candidate, sotatercept, intended to treat pulmonary arterial hypertension. The company will launch a tender offer for Acceleron shares through a subsidiary, according to…
The idea is controversial, but there are many indications that such a scenario is feasible. There are also many voices claiming that the government wants to encourage people delaying the COVID-19 vaccination to get vaccinated as soon as possible. This is because currently 16.97 million people in Poland have been vaccinated, 80% of whom are…
BioNTech has announced the establishment of a regional headquarters in Southeast Asia in Singapore. A fully integrated mRNA production facility is also to be established there with the support of the Singapore Economic Development Board. Vaccine production accelerates BioNTech plans to open an office in Singapore and begin construction of a manufacturing facility in 2021,…
Ryvu Therapeutics S.A., one of Europe’s largest innovative biotechnology companies active in the discovery and development of new oncology therapies, has announced that Vatnak Vat-Ho is joining the company as Chief Business Officer. Ryvu will gain knowledge and experience from Vatnak Vat-Ho Vatnak Vat-Ho holds a bachelor’s degree in biology from Harvard University. Ryvu‘s new…
According to the announcement, by the end of August, every willing Polish citizen is to receive the vaccination for COVID-19. In the second half of April, the vaccine for COVID-19 of the fourth company – Johnson & Johnson (J&J) – will come to Poland. This is to greatly facilitate the implementation of the National Vaccination…
Deputy Health Minister Maciej Miłkowski said that Poland will resell 4 million of the 20 million vaccines purchased from AstraZeneca. The vaccines are to be resold to countries outside the European Union (EU). Poland buys 20 million doses of AstraZeneca vaccines Deputy Health Minister Maciej Miłkowski announced that Poland will resell 4 million of…
The confusion surrounding the COVID-19 vaccine caused by the suspension of its supply to Europe has affected the vaccination schedule in our country. Pfizer informed about production limitation due to modernisation of production lines, which affected Monday’s delivery. At the moment, it is known that the Polish producer of medicines – Polfa Tarchomin – is…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.